Predictors of mortality in chest wall disease treated with noninvasive home mechanical ventilation.

RATIONALE The long-term evolution of patients with chest wall disease and chronic respiratory failure treated with noninvasive home mechanical ventilation (NIHMV) is poorly known. OBJECTIVES The aim of this prospective observational study was to analyze the variables associated with mortality in a cohort of chest wall disease patients with chronic respiratory failure undergoing long-term follow-up after starting treatment with NIHMV. METHODS Chest wall disease patients who began NIHMV between 1996 and 2005 were followed up, with death as the primary outcome. The patients' clinical characteristics, lung function, and arterial blood gases were recorded at the start of treatment. Patients were seen and evaluated 1 month after starting NIHMV. The prognostic value of clinical and functional variables were assessed by Cox regression analyses. MAIN RESULTS We included 110 patients, 61 with tuberculosis sequelae and 49 with kyphoscoliosis. By the end of follow-up, 34 patients (28%) had died. The 5-year survival was 69% in those with tuberculosis sequelae and 75% in kyphoscoliosis. PaCO(2) ≥50 mmHg at 1 month of home ventilation and comorbidity (Charlson Index ≥3) were independent predictors of mortality. CONCLUSION Our results suggest that PaCO2 levels ≥50 mmHg at 1 month after starting noninvasive home mechanical ventilation and the presence of comorbid conditions are risk factors for mortality in patients with chest wall disease. The importance of early detection of suboptimal home ventilation as well as comorbidities is highlighted.

[1]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[2]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[3]  J. Polu,et al.  Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. , 1994, Chest.

[4]  M. Mishima,et al.  Importance of the PaCO(2) from 3 to 6 months after initiation of long-term non-invasive ventilation. , 2010, Respiratory medicine.

[5]  F. Morell,et al.  Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy , 2006, European Respiratory Journal.

[6]  E. Stepanski,et al.  Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. , 2006, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[7]  W. S. Ring,et al.  Consensus Conference Report , 2002 .

[8]  J. Chevrolet,et al.  Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. , 2003, Chest.

[9]  P. Wijkstra,et al.  Home mechanical ventilatory support in patients with restrictive ventilatory disorders: a 48-year experience. , 2006, Respiratory medicine.

[10]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[11]  M. Demedts,et al.  Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation? , 2003, European Respiratory Journal.

[12]  A. Simonds,et al.  SERIES 0NONINVASIVE VENTILATION IN ACUTE AND CHRONIC RESPIRATORY FAILURE0 , 2002 .

[13]  N. Hill,et al.  Efficacy of nocturnal nasal ventilation in patients with restrictive thoracic disease. , 1992, The American review of respiratory disease.

[14]  B. Dautzenberg,et al.  Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. , 1996, Chest.

[15]  J. Ranstam,et al.  Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home. , 2006, Chest.

[16]  M. Elliott,et al.  Randomised crossover study of pressure and volume non-invasive ventilation in chest wall deformity , 2005, Thorax.

[17]  P. Ramos,et al.  Normativa sobre la ventilación mecánica a domicilio , 2001 .

[18]  M. Branthwaite,et al.  Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. , 1988, Thorax.

[19]  G. Snider,et al.  Obstructive airway disease in patients with treated pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[20]  D. Navajas,et al.  Spirometric reference values from a Mediterranean population. , 1986, Bulletin europeen de physiopathologie respiratoire.

[21]  J. Núñez,et al.  Kyphoscoliotic ventilatory insufficiency: effects of long-term intermittent positive-pressure ventilation. , 2003, Chest.

[22]  J. M. Masa Jiménez,et al.  Nasal intermittent positive pressure ventilation. Analysis of its withdrawal. , 1995, Chest.

[23]  K. Franklin,et al.  Increased survival with mechanical ventilation in posttuberculosis patients with the combination of respiratory failure and chest wall deformity. , 2008, Chest.

[24]  J. S. D. C. Escuín,et al.  Nasal intermittent positive pressure ventilation. Analysis of its withdrawal. , 1995, Chest.

[25]  P. Willcox,et al.  Chronic obstructive airways disease following treated pulmonary tuberculosis. , 1989, Respiratory medicine.

[26]  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report. , 1999, Chest.

[27]  F. Morell,et al.  Comparative study of two different modes of noninvasive home mechanical ventilation in chronic respiratory failure. , 2006, Respiratory medicine.

[28]  A K Simonds,et al.  Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey , 2005, European Respiratory Journal.

[29]  A. Simonds,et al.  Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. , 1995, Thorax.